Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial
Authors
Robert G. Bryant (ORCID: https://orcid.org/0000-0001-7943-4781)
Christian Agboton (ORCID: https://orcid.org/0000-0002-1178-2429)
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial
Robert G. Bryant, Christian Agboton, K Novák, Aviv Pudipeddi et al.
Journal
BMJ Open Gastroenterology
Topics
Inflammatory Bowel Disease
article
Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial
Robert G. Bryant, Christian Agboton, K Novák, Aviv Pudipeddi, Sudheer Kumar Vuyyuru, Blue Neustifter, Stuart Taylor, Rune Wilkens, Mariangela Allocca, I Romo Bautista, C Maaser, G Zou, Bruce E Sands, Silvio Danese, Jakob Begun, Marla Dubinsky, Remo Panaccione, Yoon-Kyo An, Krisztina B Gecse, Vipul Jairath, David T Rubin, Christopher Ma, Brian G Feagan
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ Open GastroenterologyVol. 13(1)
Institutions
Western University (CA), The University of Sydney (AU), The University of Queensland (AU), University of Calgary (CA), Concord Repatriation General Hospital (AU), Copenhagen University Hospital (DK), University of Chicago (US), Mater Research (AU), Queen Elizabeth Hospital (AU), Klinikum Lüneburg (DE), IRCCS Ospedale San Raffaele (IT), Takeda (United States) (US), Amsterdam University Medical Centers (NL), Mater Adult Hospital (AU), Alfred Health (AU), University College London (GB), Monash University (AU), Icahn School of Medicine at Mount Sinai (US)